Charles Mathys
@Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (llc)
Latest period2024 - Q3ReportedManaged Assets$1.296BTotal holdings444
Assets growth rate-19.33%Assets growth rate (2-Q avg)-2.21%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (llc)'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 444 positions.
Assets under management
The assets under management (AUM) of Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (llc) over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.296B in assets, with a quarterly growth rate of -19.33% and a 2-quarter average growth rate of -2.21%. The portfolio is managed by Charles Mathys, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
NKTRNektar The
| 0.12% | $1.496M 1.151M shares@ $1.31 avg price | Increased 10.25% |
ORICOric Pharm
| 0.12% | $1.469M 143,320 shares@ $10.25 avg price | Increased 25.32% |
KROSKeros Ther
| 0.12% | $1.437M 24,752 shares@ $58.08 avg price | Increased 10.24% |
TEVATeva Pharm
| 0.12% | $1.426M 79,132 shares@ $18.03 avg price | Increased 55.48% |
KIDSOrthopedia
| 0.11% | $1.41M 52,022 shares@ $27.11 avg price | Increased 8.17% |
ALGNAlign Tech
| 0.11% | $1.386M 5,450 shares@ $254.32 avg price | Increased 167.95% |
ATXSAstria The
| 0.11% | $1.367M 124,202 shares@ $11.01 avg price | Increased 10.25% |
OFIXOrthofix M
| 0.11% | $1.326M 84,883 shares@ $15.62 avg price | Increased 10.25% |
VSTMVerastem I
| 0.1% | $1.288M 430,669 shares@ $2.99 avg price | Increased 329.01% |
TMCITreace Med
| 0.1% | $1.263M 217,755 shares@ $5.8 avg price | Increased 2.25% |